Horizon Pharma reported $2.13B in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
ALKERMES ALKS:US USD 263.96M 9.31M
Amgen AMGN:US USD 9.5B 4.3B
AstraZeneca AZN:LN USD 4.46B 359M
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Cara Therapeutics CARA:US USD 42.81M 3.91M
Coherus Biosciences CHRS:US USD 286.8M 11.32M
Eli Lilly And LLY:US USD 2.62B 5.5M
Endo International Ordinary Shares ENDP:US USD 1.05B 137.68M
Horizon Pharma HZNP:US USD 2.13B 237.96M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Novartis NOVN:VX USD 8.73B 5.1B
Pacira Pharmaceuticals PCRX:US USD 109.42M 12.64M
Perrigo Ordinary Shares PRGO:US USD 468.7M 16.6M
Prestige Brands PBH:US USD 42.44M 6.57M
Revance Therapeutics RVNC:US USD 104.49M 35.07M
Supernus Pharmaceuticals SUPN:US USD 111.49M 61.94M
Takeda 4502:JP JPY 798.14B 152.15B
Teva Pharmaceutical Industries TEVA:US USD 2.22B 167M
Valeant Pharmaceuticals VRX:CN USD 486M 173M
Xeris Pharmaceuticals Inc XERS:US USD 84.11M 11.23M
Zoetis ZTS:US USD 2.5B 145M